Vericel (VCEL) Preferred Dividend Payments (2012 - 2013)
Vericel's (VCEL) quarterly Preferred Dividend Payments came in at $1.3 million in Q1 2013, up 337.02% year-on-year from $289000.0 in Q1 2012, and up 0.64% quarter-over-quarter from $1.3 million in Q4 2012.
Vericel (VCEL) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Vericel has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $1.3 million for Q1 2013.
- Preferred Dividend Payments for Q1 2013 came in at $1.3 million, up 337.02% year-over-year; the trailing twelve-month figure through Jun 2013 was $3.7 million (changed N/A YoY), and the FY2012 annual result was $4.0 million, changed N/A from the prior year.
- Preferred Dividend Payments came in at $1.3 million for Q1 2013 at Vericel, up from $1.3 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.3 million in Q1 2013 to a low of $289000.0 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 1.26 Mn |
| Dec 31, 2012 | 1.26 Mn |
| Sep 30, 2012 | 1.22 Mn |
| Jun 30, 2012 | 1.23 Mn |
| Mar 31, 2012 | 289,000.00 |